AR120710A1 - Método para la recuperación continua de proteínas - Google Patents

Método para la recuperación continua de proteínas

Info

Publication number
AR120710A1
AR120710A1 ARP200103431A ARP200103431A AR120710A1 AR 120710 A1 AR120710 A1 AR 120710A1 AR P200103431 A ARP200103431 A AR P200103431A AR P200103431 A ARP200103431 A AR P200103431A AR 120710 A1 AR120710 A1 AR 120710A1
Authority
AR
Argentina
Prior art keywords
protein
proteins
fluid
continuous recovery
recovery
Prior art date
Application number
ARP200103431A
Other languages
English (en)
Inventor
Daniel Fleischanderl
Christoph Dattenboeck
Katerina Petrushevska-Seebach
Thomas Gatternig
Martin Purtscher
Alois Jungbauer
Hannah Engelmaier
Nikolaus Hammerschmidt
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of AR120710A1 publication Critical patent/AR120710A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se relaciona con un método para la recuperación continua de una proteína a partir de un fluido, que comprende precipitar la proteína en el fluido y separar la proteína precipitada del fluido. También provee un sedimentador de placa inclinada que puede ser utilizado para dicha recuperación continua de proteínas. Reivindicación 5: El método de una cualquiera de las reivindicaciones 1 a 4, en donde la proteína es un factor de coagulación sanguínea.
ARP200103431A 2019-12-12 2020-12-10 Método para la recuperación continua de proteínas AR120710A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962947209P 2019-12-12 2019-12-12

Publications (1)

Publication Number Publication Date
AR120710A1 true AR120710A1 (es) 2022-03-09

Family

ID=74125137

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103431A AR120710A1 (es) 2019-12-12 2020-12-10 Método para la recuperación continua de proteínas

Country Status (7)

Country Link
US (1) US20230017907A1 (es)
EP (1) EP4073104A2 (es)
JP (1) JP2023506467A (es)
CN (1) CN115380044A (es)
AR (1) AR120710A1 (es)
TW (1) TW202136283A (es)
WO (1) WO2021116273A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240139382A (ko) * 2023-03-14 2024-09-23 씨제이제일제당 (주) 여과 유속이 개선된 아미노산의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US753646A (en) 1903-07-09 1904-03-01 James Allen Swinehart Tire for vehicle-wheels.
US2793186A (en) 1954-01-08 1957-05-21 Ca Nat Research Council Apparatus for classifying or settling fluid suspensions
US2883059A (en) * 1957-05-10 1959-04-21 Ca Nat Research Council Settling device
JP2002532238A (ja) 1998-12-17 2002-10-02 ルイス・カストロ・ゴメス 金粒子の分離方法及び装置
EP1524321B2 (en) 2003-10-16 2014-07-23 Sequenom, Inc. Non-invasive detection of fetal genetic traits
US20100203204A1 (en) * 2009-02-11 2010-08-12 Segall Kevin I Production of Soy Protein Product Using Calcium Chloride Extraction ("S7300/S7200")
CN112334208B (zh) * 2018-06-18 2023-09-01 武田药品工业株式会社 用于连接至具有板沉降器的组件的底部区段以及该组件

Also Published As

Publication number Publication date
CN115380044A (zh) 2022-11-22
EP4073104A2 (en) 2022-10-19
JP2023506467A (ja) 2023-02-16
WO2021116273A2 (en) 2021-06-17
US20230017907A1 (en) 2023-01-19
WO2021116273A3 (en) 2021-08-05
TW202136283A (zh) 2021-10-01

Similar Documents

Publication Publication Date Title
BR112018007422A2 (pt) anticorpos anti-age e métodos de uso dos mesmos
EA202090897A1 (ru) Новые слитые белки на основе ферритина человека и расщепляемых протеазой пептидов и их применение в качестве носителей химиотерапевтических средств
BR112017008525A2 (pt) proteína de fusão isolada, e, métodos para tratamento ou alívio de um sintoma de uma doença ou distúrbio, para tratamento ou alívio de uma inflamação ou um sintoma de uma doença ou distúrbio inflamatório e para redução do risco de infecção em um indivíduo.
BR112017023391A2 (pt) ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele?
AR120710A1 (es) Método para la recuperación continua de proteínas
EA202191133A1 (ru) Сигнатуры интерферона типа i и способы их применения
MX2019005693A (es) Factor viii direccionado a los globulos rojos y metodo para su uso.
EA201790563A1 (ru) Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой
BR112014000278A2 (pt) método para o preparo de um concentrado de imunoglobulinas polivalentes
BR112018068838A2 (pt) oclusão de fístula pancreática
BR112018014762A2 (pt) método de tratamento da doença de alzheimer (da) precoce
BR112015019197A2 (pt) tratamento de doença de enxerto versus hospedeiro em pacientes transplantados
BR112022020444A2 (pt) Composições e métodos para o tratamento de distúrbios de agregação de proteínas
BR112017002083A2 (pt) sistema de bioprocessamento de microescala e método para fabricação de proteína de sangue humano
RU2012149809A (ru) Способ прогнозирования прогрессирования первичной открытоугольной глаукомы
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
BR112017021016A2 (pt) preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
Razumova et al. Uveitis in spondyloarthritis patients and its association with HLA-B27 histocompatibility antigen: prospective study
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
PL418202A1 (pl) Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika
Mal'chevskiĭ Character of changes in the rheological parameters of blood in patients with heart failure III-IV FC treated by the combination therapy with plasmapheresis
EA201400959A1 (ru) Полученная из остеопротегерина композиция и ее применение
RU2015117686A (ru) Определение содержания GC-богатой последовательности генома (GC-ДНК) в составе циркулирующей внеклеточной ДНК плазмы периферической крови как способ определения уровня гибели клеток при хронических заболеваниях, при физиологических состояниях (беременность) и при хроническом действии неблагоприятных факторов окружающей среды на организм человека
Gramatzki et al. Differences Between Gvhd and GVL May be Rather Quantitative and Not Dependent on a Malignant Transformation of the Target Cell
Parshukova et al. Potancial role of antibodies with catalytic activity in therapy of schizophrenia